Economic Atlas
Data may be delayed — last successful sync 2026-09-26 (18 days ago). Figures reflect the most recent completed ingest.
Companies/Pharmadrug Inc.
Company profile

Pharmadrug Inc.

OTC: LMLLF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#1162 of 1,417 Healthcare companies by revenue
EA Score
——
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$274.0k
Employees
9
as of 2026-09-25
Market cap
$590.5k
as of 2026-09-25

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$274.0k-383.1k CAD2025
Operating income-$161.5k-225.7k CAD2025
Total assets$402.2k551.2k CAD2025
Liabilities$1.6M2.2M CAD2025
Equity-$1.3M-1.8M CAD2025

Revenue trend

FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Pharmadrug Inc.’s revenue?

Pharmadrug Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare
Pond Technologies Holdings Inc.21DPlanet Based Foods Global Inc.38DChitogenX Inc.——4Cable TV International, Inc.——Actavia Life Sciences, Inc.——Biocure Technology Inc.——
Key facts
CEODavid Kideckel
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: LMLLF
Employees9
IPO date2017-05-19
Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.